Cooper Companies (NASDAQ:COO) Announces Earnings Results, Beats Estimates By $0.03 EPS

Cooper Companies (NASDAQ:COO - Get Free Report) released its quarterly earnings data on Thursday. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.03, Zacks reports. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. During the same period in the previous year, the company posted $0.85 EPS. The company's revenue was up 6.3% compared to the same quarter last year. Cooper Companies updated its FY 2025 guidance to 4.050-4.110 EPS.

Cooper Companies Stock Performance

Shares of NASDAQ:COO traded down $11.02 during trading on Friday, hitting $68.94. 8,291,770 shares of the company traded hands, compared to its average volume of 1,531,454. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The business's fifty day moving average is $79.82 and its 200-day moving average is $88.37. The stock has a market capitalization of $13.79 billion, a price-to-earnings ratio of 35.35, a PEG ratio of 2.25 and a beta of 1.08. Cooper Companies has a one year low of $65.95 and a one year high of $112.38.

Institutional Trading of Cooper Companies

A hedge fund recently raised its stake in Cooper Companies stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 48.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,407 shares of the medical device company's stock after buying an additional 7,363 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Cooper Companies were worth $1,890,000 as of its most recent SEC filing. Institutional investors and hedge funds own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Robert W. Baird dropped their price objective on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research report on Friday. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $76.00 target price (down previously from $110.00) on shares of Cooper Companies in a research note on Friday. Wells Fargo & Company cut their price objective on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a report on Friday. Piper Sandler reiterated an "overweight" rating and set a $105.00 target price (down from $115.00) on shares of Cooper Companies in a research note on Friday. Finally, Wall Street Zen upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating in a research note on Friday. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $100.38.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.